signaling of bipolar cells (ps < .005). The schizophrenia group was also characterized by a weaker PhNR (p<.05). Weaker retinal cell responses were related to contrast sensitivity impairments in the schizophrenia group (ps < .05 and .001), but not to visual acuity or contour integration. Reduced responsiveness to low-intensity light was related to more severe negative symptoms, suggesting a reduced dynamic range within which environmental events (i.e., salience) are represented. Measures of retinal cell function were not related to antipsychotic medication dose. Preliminary findings indicate that attenuated fERG signals are not associated with weaker visual cortical responses (EEG-measured VEPs), presumably due to gain control mechanisms. We will report on the extent to which fERG anomalies are related to retinal structural changes and comorbid medical conditions. Discussion: Reduced signaling of photoreceptor, bipolar, and ganglion cells are characteristics of schizophrenia, and are not related to extent of antipsychotic medication use. These changes are related to reduced contrast sensitivity and increased negative symptoms, and may reflect an attenuated ability to accurately represent changes in the intensity of environmental stimuli. Data collection is ongoing for studies examining relationships between ERG indices and VEPs and medical comorbidities.
ELECTRORETINOGRAPHIC ANOMALIES SEEN IN PATIENTS AFFECTED BY SCHIZOPHRENIA OR BIPOLAR DISORDER ARE DETECTABLE EARLY IN CHILDREN BORN TO AN AFFECTED PARENT: IMPLICATIONS FOR THE STAGING OF RISK STATUS IN CHILDHOOD-ADOLESCENCE
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Background: Adult patients having schizophrenia, bipolar disorder or major depression display indicators of brain dysfunctions that may be detectable in healthy children-adolescents at genetic risk, such as those born to an affected parent (Maziade, New Eng J Med 2017; Schizophr Res 2013) . For instance, cognitive deficits are displayed by both adult patients and children at risk (Maziade, Schizophr Bull 2011) . We had reported that schizophrenia patients present diminished amplitudes and delayed latencies of rod and cone photoreceptor responses (Hébert, Schizophr Res, 2015) and we recently found that bipolar patients have similar ERG anomalies. We had also reported preliminary data in a small sample of 29 children born to an affected parent showing that young offspring had rod diminished amplitudes (Hébert, Biol Psychiatry 2010). The present objectives were i) under the hypothesis that offspring would display many of the ERG anomalies that schizophrenia or mood disorder patients carry (Hébert, Schizophr Res 2015; Prog Neuropsychopharmacol Biol Psychiatry 2017) , to look for cone and rod response anomalies in a large sample of young high-risk offspring; ii) to describe the relationship between ERG anomalies and other risk endophenotypes in the offspring; and iii) look at the relationship between ERG anomalies and the risk clusters already shown to predict later transition to illness. Methods: The sample consisted of 84 young offspring (aged 6 to 27) of a parent affected by schizophrenia or bipolar disorder, compared to 224 healthy controls balanced for age and sex. Full-field cone and rod ERG was measured in non-dilated eyes for all subjects. In the young offspring, we also collected measures of different cognitive domains, attenuated symptoms of psychosis, non-psychotic DSM diagnosis and/or an episode of poor GAF functioning in childhood-adolescence, childhood trauma, and cannabis use (Paccalet, Schizophr Res 2016).
Results: In comparison to controls the offspring displayed three ERG anomalies that were observed in adult patients: prolonged cone b-wave latency (p=0.04), diminished rod b-wave amplitude (p=0.04) and prolonged rod b-wave latency (p=0.006). These ERG anomalies were shared by offspring of a parent with schizophrenia or bipolar disorder, an observation of ERG commonality that we had made in adult patients. The three ERG amplitude and latency anomalies tended to aggregate in a child at risk, a trend we also observed in another endophenotype modality such as deficits in different cognitive domains. However, in these high-risk children and adolescents, the patterns of aggregation suggest that ERG anomalies would depict another risk pathway than that marked by cognitive deficits. Discussion: First, ERG anomalies in high-risk children have neurobiological implications for future research on the illness neurodevelopment. Second, as found for other modalities of risk endophenotypes in children at genetic risk (Maziade, New Eng J Med 2017), multiple rod and cone ERG anomalies tended to cluster together in a child. Such an aggregation may be compatible with the multifactorial polygenic theory with a threshold. Remarkably, a clustering of risk indicators is also observed in children at risk of metabolic cardiovascular disorders and is presently considered in practice guidelines for these children. Background: Problems with cognitive function are found in many major psychiatric disorders. In schizophrenia and attention deficit hyperactivity disorder (ADHD), they are among the core symptoms. Based on a growing recognition that there is little diagnostic specificity for any single cognitive impairment, there is an increasing emphasis on investigating impairments across psychiatric disorders. This approach, which is consistent with the NIMH Research Domain Criteria initiative, is expected to lead to a better understanding of the neurobiological mechanisms involved in cognitive deficits. An increase in neuronal background noise has been identified as a neuronal correlate of inattention. Because the dopamine system has been found to play a critical role in modulating neuronal noise, dopamine dysfunction may play a substantial role in generating the excessive noise that has been found to characterize information processing in both schizophrenia and ADHD. This issue can be studied noninvasively via electrophysiological examination of the retina, a distinct neural network. Both basic research and human studies indicate that retinal information processing is under strong dopaminergic modulation (Bubl, Biol. Psychiatry, 2010; Bubl, Br J Psychiatry, 2012) . We have previously demonstrated an elevated level of background noise at a very early stage in visual information processing in untreated patients with ADHD (Bubl, Plos One, 2015). Moreover, background noise was associated with inattention measures in these subjects.
To further address the hypothesis that elevated retinal noise reflects dopaminergic dysfunction, we report here on a new study that compared retinal background noise in patients with ADHD both before and after therapy, as well as in patients with schizophrenia. Methods: Neuronal noise was assessed using pattern electroretinogram (PERG), an objective electrophysiological measure for retinal network function from the photoreceptors to the retinal ganglion cells. A total of 20 patients diagnosed with ADHD were tested both before and after treatment with methylphenidate (MPH). The control group consisted of 21 healthy subjects. The PERGs were recorded in a steady state mode in response to checkerboard stimuli of 12 reversals/s. Data collection with people with schizophrenia is ongoing, and results will be reported at SIRS. Results: Before treatment, the patients with ADHD presented with elevated background noise (higher by 127%) in comparison to the control group. After treatment, noise level did not differ from what was observed in the control group. Retinal background noise was found to be highly correlated with the severity of the ADHD symptoms. The results will be discussed in relationship to our findings in patients with schizophrenia. Discussion: These data provide further evidence for the hypothesis that elevated background noise is linked to ADHD and cognitive deficits. The findings are of special relevance because ADHD is a disorder with a dedicated treatment option for cognitive symptoms. Interestingly, a similar pathophysiological mechanism for cognitive dysfunction has been proposed for both schizophrenia and ADHD. However, because ADHD medications, such as MPH, typically elevate dopamine levels, potentially leading to exacerbation of psychotic symptoms, different approaches for treating cognitive symptoms in schizophrenia need to be explored. On this basis, current approaches used to target neuronal noise and cognitive symptoms in patients with schizophrenia will be discussed and their relevance for future research will be addressed. Background: Individuals with schizophrenia are at increased risk for cardiovascular diseases, and this risk cannot be fully explained by antipsychotic medications or lifestyle factors. Retinal imaging offers a non-invasive means of visualizing the microvasculature in living individuals with schizophrenia. Here we test whether individuals with schizophrenia exhibit retinal microvascular abnormality (Meier et al., AJP, 2013) , and test for overlap in the genetic variants associated with schizophrenia and retinal microvascular abnormality. Methods: To test whether individuals diagnosed with schizophrenia showed microvascular abnormality, we used data from the Dunedin Study, a representative cohort of 1,000 New Zealanders followed from birth to age 38. The cohort underwent retinal imaging at age 38, and retinal venular (small veins) and arteriolar (small arteries) diameters were obtained. Analyses compared individuals with schizophrenia (n=27), healthy individuals (n=412), and individuals with medical or psychiatric conditions (ns ranged from 110-210) on retinal vessel diameter. To test for overlap in the genetic variants associated with schizophrenia and retinal vessel diameter, we used linkage disequilibrium-score regression (LD regression) to obtain the genetic correlation between schizophrenia and retinal vessel diameter. This method requires only GWAS (genome wide associate studies) summary statistics rather than actual genotypes. Summary statistics for schizophrenia and retinal vessel diameter came from published meta-analyses. Results: Adults diagnosed with schizophrenia had wider retinal venules (standardized mean=0.59) compared with same-age healthy adults (standardized mean=-0.20) and compared with individuals diagnosed with hypertension, diabetes, and tobacco dependence. Findings could not be explained by antipsychotic medication, as venular diameter was similar in the subset of individuals diagnosed with schizophrenia who had not taken antipsychotic medication in the year prior to retinal imaging (n=22; standardized mean=0.69). There were no differences in arteriolar diameter between individuals diagnosed with schizophrenia and all other groups. Results from LD regression showed a small genetic correlation between schizophrenia and venular diameter (r=0.05, p=.31) and a slightly larger genetic correlation between schizophrenia and arteriolar diameter (r=0.17, p=.02). Discussion: Wider venular diameter is a distinguishing feature of schizophrenia, but genetic variants associated with schizophrenia overlap more strongly with variants associated with arteriolar diameter. It is possible that environmental influences associated with schizophrenia tend to narrow arterioles, obscuring a phenotypic link between schizophrenia and wider arterioles. Pathophysiological mechanisms underlying vessel diameter, including inflammation and endothelial dysfunction, might be related to the development of schizophrenia, and particular genes might contribute to both schizophrenia and arteriolar diameter. Findings will be discussed in relation to links between retinal vessel diameter and IQ (Shalev, Meier et al., Psychol Sci, 2013) and depression (Meier et al., Psychosom Med, 2014) .
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